𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation

✍ Scribed by Kana Tojo; Yoshiki Sekijima; Tamio Suzuki; Noriyuki Suzuki; Yasushi Tomita; Kunihiro Yoshida; Takao Hashimoto; Shu-ichi Ikeda


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
112 KB
Volume
21
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A family with dystonia associated with dyschromatosis symmetrica hereditaria (DSH), mental deterioration, and tissue calcification is described. The proband possessed an adenosine deaminase acting on the RNA 1 gene (ADAR1) mutation Gly1007Arg. This ADAR1 mutation could disturb RNA editing at Q/R sites of glutamate receptor in the brain and increase Ca^2+^ influx into neurons, which is thought to induce dystonia and mental deterioration. The observations in our family raise the possibility that the ADAR1 mutation might be a direct cause or a predisposing factor for heredodegenerative dystonia. Further investigation of ADAR1 mutations will shed light on the genotype–phenotype correlation in DSH. Β© 2006 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Seven novel mutations of the ADAR gene i
✍ Xue-Jun Zhang; Ping-Ping He; Ming Li; Chun-Di He; Kai-Lin Yan; Yong Cui; Sen Yan πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 505 KB

Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominant pigmentary genodermatosis characterized by hyperpigmented and hypopigmented macules of on the extremities and caused by the mutations in the ADAR gene(also called DSRAD) encoding for RNA-specific adenosine deaminase. Here we report

Novel GCH1 mutation in a Brazilian famil
✍ Sarah Teixeira Camargos; Francisco Cardoso; Parastoo Momeni; Juliana Gurgel Gian πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

## Abstract Dopa responsive Dystonia (DRD) was first described in 1971 and typically begins at childhood with gait dysfunction caused by foot dystonia progressing to affect other extremities. There is marked diurnal fluctuation and sustained improvement of symptoms with low dose levodopa therapy. H